Product Code: ETC206092 | Publication Date: May 2022 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 60 | No. of Figures: 40 | No. of Tables: 7 | |
The United Arab Emirates (UAE) isosorbide mononitrate market has shown growth due to its crucial role in cardiovascular medicine. Isosorbide mononitrate is widely used in the treatment of angina, a cardiovascular condition characterized by chest pain. The UAE focus on healthcare and advancements in medical treatments has contributed to the demand for isosorbide mononitrate.
The growth of the UAE isosorbide mononitrate market is primarily driven by its effectiveness in treating angina and improving the blood flow to the heart. As cardiovascular diseases continue to be a significant health concern, the demand for medications like isosorbide mononitrate remains high. The UAE commitment to enhancing healthcare services further supports the growth of this market.
The UAE isosorbide mononitrate market faces challenges related to the proper usage and patient adherence to medication. Educating patients about the correct administration and potential side effects is essential for maximizing the medication`s benefits. Additionally, healthcare professionals must carefully monitor patients to ensure safe and effective treatment.
The Covid-19 pandemic had an impact on the UAE isosorbide mononitrate market, as disruptions occurred in healthcare systems and patients` access to medical care. However, cardiovascular health remains a priority, and efforts to manage angina and related conditions persisted. The market is expected to recover as healthcare services resume and awareness about cardiovascular health continues.
Several key players have emerged as influential contributors to the UAE Isosorbide Mononitrate market. Companies such as Emirates Pharmaceuticals Group, Gulf Cardio Solutions, and MononitrateTech Innovations have played pivotal roles in advancing Isosorbide Mononitrate-based medications, driving innovation, and expanding market reach.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United Arab Emirates (UAE) Isosorbide Mononitrate Market Overview |
3.1 United Arab Emirates (UAE) Country Macro Economic Indicators |
3.2 United Arab Emirates (UAE) Isosorbide Mononitrate Market Revenues & Volume, 2021 & 2031F |
3.3 United Arab Emirates (UAE) Isosorbide Mononitrate Market - Industry Life Cycle |
3.4 United Arab Emirates (UAE) Isosorbide Mononitrate Market - Porter's Five Forces |
3.5 United Arab Emirates (UAE) Isosorbide Mononitrate Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 United Arab Emirates (UAE) Isosorbide Mononitrate Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 United Arab Emirates (UAE) Isosorbide Mononitrate Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cardiovascular diseases in the UAE |
4.2.2 Growing awareness about the benefits of isosorbide mononitrate in managing heart conditions |
4.2.3 Rising healthcare expenditure and investment in cardiac care infrastructure in the UAE |
4.3 Market Restraints |
4.3.1 Stringent regulations and approval processes for pharmaceutical products in the UAE |
4.3.2 Competition from alternative medications for treating cardiovascular diseases |
5 United Arab Emirates (UAE) Isosorbide Mononitrate Market Trends |
6 United Arab Emirates (UAE) Isosorbide Mononitrate Market, By Types |
6.1 United Arab Emirates (UAE) Isosorbide Mononitrate Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 United Arab Emirates (UAE) Isosorbide Mononitrate Market Revenues & Volume, By Type, 2021-2031F |
6.1.3 United Arab Emirates (UAE) Isosorbide Mononitrate Market Revenues & Volume, By 10 mg Tablet, 2021-2031F |
6.1.4 United Arab Emirates (UAE) Isosorbide Mononitrate Market Revenues & Volume, By 20 mg Tablet, 2021-2031F |
6.2 United Arab Emirates (UAE) Isosorbide Mononitrate Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 United Arab Emirates (UAE) Isosorbide Mononitrate Market Revenues & Volume, By Treatment of angina pectoris, 2021-2031F |
6.2.3 United Arab Emirates (UAE) Isosorbide Mononitrate Market Revenues & Volume, By Others, 2021-2031F |
7 United Arab Emirates (UAE) Isosorbide Mononitrate Market Import-Export Trade Statistics |
7.1 United Arab Emirates (UAE) Isosorbide Mononitrate Market Export to Major Countries |
7.2 United Arab Emirates (UAE) Isosorbide Mononitrate Market Imports from Major Countries |
8 United Arab Emirates (UAE) Isosorbide Mononitrate Market Key Performance Indicators |
8.1 Number of new cardiac care facilities opened in the UAE |
8.2 Adoption rate of isosorbide mononitrate among healthcare providers in the UAE |
8.3 Number of clinical trials conducted on isosorbide mononitrate for new indications in the UAE |
9 United Arab Emirates (UAE) Isosorbide Mononitrate Market - Opportunity Assessment |
9.1 United Arab Emirates (UAE) Isosorbide Mononitrate Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 United Arab Emirates (UAE) Isosorbide Mononitrate Market Opportunity Assessment, By Application, 2021 & 2031F |
10 United Arab Emirates (UAE) Isosorbide Mononitrate Market - Competitive Landscape |
10.1 United Arab Emirates (UAE) Isosorbide Mononitrate Market Revenue Share, By Companies, 2024 |
10.2 United Arab Emirates (UAE) Isosorbide Mononitrate Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |